News

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.
It's a big day for Rainbow Six Siege, as the game's "largest and most transformative" update in the game's 10-year history is out now, free for everyone on all platforms. The update, Siege X ...
Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as expected in the third quarter of this year.
A significant trading signal occurred for Regeneron Pharma stock at a price of $501.83, after which REGN rose up to 3.2%.
-Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday.
Don't miss the Clash Elite Trailer for Rainbow Six Siege X, a new iteration of the tactical first-person shooter developed by Ubisoft. Players can now access a new tactical look with the Clash ...
Time now for to watch Friday, June 13th, starting off on the consumer monthly consumer sentiment data for June. It's coming out in the morning. Economist forecasting that number to rise compared ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has maintained its Overweight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ ...
An analysis by dongou.tech tracked companies that displayed Pride-themed rainbow logos on LinkedIn. Of 344 companies that used rainbow logos in 2023, 61% did so again in 2024, and only 46% of ...
Don’t call Rainbow Six Siege X a sequel as it’s much of the same, but it remains the most significant evolution in the FPS game’s history.